Peptides have emerged as a focal point in molecular and biological research, providing a promising avenue for understanding ...

The following is a summary of “Impact of sodium-glucose cotransporter 2 inhibitors on catheter ablation for atrial fibrillation in heart failure patients without type-2 diabetes,” published in the ...

Myocarditis is a rare yet serious condition known for the inflammation of the heart muscle, also known as the myocardium. In severe cases of myocarditis, the heart muscle becomes extremely weak and ...

Inflammation of the heart muscle, also known as myocarditis, can be caused by various viral infections. Parvovirus B19, known ...

FATIGUE is quite normal for this time of year, especially after the festive period. But it can also be a sign that you are ...

GlobalData expects that the US will contribute the most to the growth of the heart failure market due to the higher ...

However, despite the advances in the field and the identification of numerous potential candidates, their implementation in clinical practice beyond natriuretic peptides and troponins is mostly ...

The use of β blockers in congestive heart failure presents a therapeutic challenge for patients with acute episodes of decompensation. Such patients may be less responsive to positive inotropic ...

Carperitide is under clinical development by Daiichi Sankyo and currently in Phase II for Contrast Induced Nephropathy.

Roach: My husband is 73 and was diagnosed with heart failure and a severely dilated left ventricle. At the time, he was pumping 10 litres per minute. He had a proBNP natriuretic peptide level over ...

which may open the door to new ways to treat and perhaps someday cure heart failure. A research team co-led by a physician-scientist at the University of Arizona College of Medicine -- Tucson's ...